Brigham and Women’s Hospital

Dissecting the Contribution of Mutated T Cells to Inflammation in Clonal Hematopoiesis and Myelodysplastic Syndromes

The Vera and Joseph Dresner Foundation granted Brigham and Women’s Hospital a $250,000 grant over two years for early career investigator Dr. Peter van Galen.

Dr. van Galen with the support of his mentor, Dr. Nancy Berliner, seeks to gain a better understanding of the role that DNMT3A-mutated T cells play in the pathophysiology of myelodysplastic syndromes.

Learn more about Brigham and Women’s Hospital.